At Akrimax, our approach is to identify, acquire and market innovative pharmaceutical products. We engage in product life cycle management activity (including Phase IV trials and patient registries) to bring new information and treatments to the healthcare community. Akrimax personnel hold several product formulation patents and have been instrumental in bringing novel formulations of well-known drugs to market. Most of our products enjoy patent protection and have no generic equivalents.